Bringing the fundamentals into focus…
Back to LENZ Therapeutics, Inc.
How LENZ Therapeutics, Inc. stacks up
LENZ · against 91 other Healthcare companies of similar size
Growth
88/ 100
Near the top of its peers.
Ranked #15 of 92 · scores higher than 84% of peers
Bars: peers in each 10-point band of the growth score8 peers with a growth score of 80–89, including LENZ · Click a bar to see the companies
Why growth scores 88?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its revenue growth, which is stronger than most Healthcare peers.
- The loss per share widened. Earnings per share growth: — vs peer median 9.8%
- 3-year revenue growth is close to the peer norm. 3-year revenue growth: 8.4% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 98% of peers. Revenue growth: 329.5% vs peer median 6.1%
Metric by metric
Position: dot = LENZ, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | LENZ | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 98 reported | 329.5% | 5.1% | 98% | 33% | |
| Earnings per share growthHigher is better · 31 reported | Not reported | 5.0% | — | — | 33% |
| 3-year revenue growthHigher is better · 90 reported | 8.4% | 2.8% | 66% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around LENZ| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 592M ILS (≈$160M) | 99 | 84 | |
| 1 | 90M USD | 99 | 27 | |
| 1 | 649M SEK (≈$65M) | 99 | 29 | |
| 1 | 97M USD | 99 | 63 | |
| 5 | 5.7B TWD (≈$177M) | 98 | 65 | |
| 12 | 144.1B KRW (≈$104M) | 93 | 45 | |
| 13 | 287.6B KRW (≈$207M) | 92 | ||
| 14 | 6.2B TWD (≈$193M) | 90 | 42 | |
| 15 | 106M EUR (≈$116M) | 88 | 46 | |
| 15 | 110M USD | 88 | 54 | |
| 17 | 188M CHF (≈$216M) | 87 | 74 | |
| 18 | 2.9B TWD (≈$90M) | 85 | 58 | |
| 19 | 126M USD | 84 | 32 | |
| 20 | 5.3B TWD (≈$165M) | 82 | 69 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score